Multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: an NF Clinical Trials Consortium study

被引：0

作者：

Plotkin, Scott ^{[1
]}

Tonsgard, James ^{[2
]}

Ullrich, Nicole ^{[3
]}

Allen, Jeffrey ^{[4
]}

Blakeley, Jaishri ^{[5
]}

Rosser, Tena ^{[6
]}

Clapp, David ^{[7
]}

Campion, Jian ^{[8
]}

Fisher, Michael ^{[9
]}

Cutter, Gary ^{[10
]}

Korf, Bruce ^{[10
]}

Packer, Roger ^{[11
]}

Thomas, Coretta ^{[10
]}

Karajannis, Matthias ^{[12
]}

机构：

[1] Massachusetts Gen Hosp, Neurol, Boston, MA 02114 USA

[2] Univ Chicago, Chicago, IL 60637 USA

[3] Boston Childrens Hosp, Boston, MA USA

[4] NYU, Langone Med Ctr, New York, NY USA

[5] Johns Hopkins, Baltimore, MD USA

[6] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA

[7] Indiana Univ, Indianapolis, IN 46204 USA

[8] Washington Univ, St Louis, Ukraine

[9] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA

[10] Univ Alabama, Birmingham, AL USA

[11] Childrens Natl Med Ctr, Neurol Dept, Washington, DC 20010 USA

[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

NEUROLOGY | 2018年 / 90卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

S23.004

引用

页数：3

共 50 条

[1] MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY
Plotkin, Scott
Tonsgard, James
Ullrich, Nicole
Allen, Jeffrey
Blakeley, Jashri
Rosser, Tena
Campian, Jian
Clapp, Wade
Fisher, Michael
Cutter, Gary
Korf, Bruce
Packer, Roger
Thomas, Coretta
Karjannis, Matthias
NEURO-ONCOLOGY, 2017, 19 : 215 - 215
[2] PRELIMINARY REPORT OF A MULTICENTER, PHASE 2 STUDY OF BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY
Tonsgard, James
Ullrich, Nicole
Blakeley, Jaishri
Rosser, Tena
Packer, Roger
Korf, Bruce
Fisher, Michael
Cutter, Gary
Plotkin, Scott
Karajannis, Matthias
Allen, Jeffrey
Clapp, D. Wade
Thomas, Coretta
Campian, Jian
NEURO-ONCOLOGY, 2018, 20 : 144 - 144
[3] Preliminary report of a multicenter, phase 2 study of bevacizumab in children and adults with neurofibromatosis 2 and progressive vestibular schwannomas: An NF Clinical Trials Consortium study.
Plotkin, Scott Randall
Tonsgard, James H.
Ullrich, Nicole J.
Allen, Jeffrey C.
Rosser, Tena L.
Campian, Jian Li
Clapp, David Wade
Fisher, Michael J.
Cutter, Gary R.
Korf, Bruce R.
Packer, Roger
Thomas, Coretta
Karajannis, Matthias A.
Blakeley, Jaishri O'Neill
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
[4] MAINTENANCE CHEMOTHERAPY USING BEVACIZUMAB FOR NEUROFIBROMATOSIS 2 PATIENTS WITH HEARING LOSS AND PROGRESSIVE VESTIBULAR SCHWANNOMAS: AN NF CLINICAL TRIALS CONSORTIUM STUDY (NF104)
Plotkin, Scott
Tonsgard, James
Ullrich, Nicole
Allen, Jeffrey
Blakeley, Jaishri
Dhall, Girish
Campian, Jian
Clapp, Wade
Fisher, Michael
Cutter, Gary
Korf, Bruce
Packer, Roger
Thomas, Coretta
Edwards, Lloyd
Karajannis, Matthias
NEURO-ONCOLOGY, 2020, 22 : 43 - 43
[5] Phase II study of everolimus in children and adults with neurofibromatosis type 2 and progressive vestibular schwannomas
Karajannis, Matthias A.
Legault, Genevieve
Hagiwara, Mari
Giancotti, Filippo G.
Filatov, Alexander
Derman, Anna
Hochman, Tsivia
Goldberg, Judith D.
Vega, Emilio
Wisoff, Jeffrey H.
Golfinos, John G.
Merkelson, Amanda
Roland, J. Thomas
Allen, Jeffrey C.
NEURO-ONCOLOGY, 2014, 16 (02) : 292 - 297
[6] BEVACIZUMAB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 2 AND SYMPTOMATIC VESTIBULAR SCHWANNOMAS
Blakeley, Jaishri
Ye, Xiaobu
Bergner, Amanda
Dombi, Eva
Zalewski, Christopher
Follmer, Krista
Halpin, Chris
Fayad, Laura
Jacobs, Michael
Baldwin, Andrea
Langmead, Shannon
Whitcomb, Trish
Jennings, Dominique
Widemann, Brigitte
Plotkin, Scott
NEURO-ONCOLOGY, 2013, 15 : 101 - 101
[7] PHASE II STUDY OF RAD001 IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS
Karajannis, Matthias
Legault, Genevieve
Hagiwara, Mari
Vega, Emilio
Merkelson, Amanda
Wisoff, Jeffrey
Golfinos, John
Roland, J. Thomas
Allen, Jeffrey
NEURO-ONCOLOGY, 2013, 15 : 35 - 35
[8] PHASE II TRIAL OF LAPATINIB IN CHILDREN AND ADULTS WITH NEUROFIBROMATOSIS TYPE 2 AND PROGRESSIVE VESTIBULAR SCHWANNOMAS
Legault, Genevieve
Hagiwara, Mari
Ballas, Marc
Brown, Krysten
Vega, Emilio
Nusbaum, Annette
Bloom, Michael
Hochman, Tsivia
Goldberg, Judith
Golfinos, John
Roland, J. Thomas
Allen, Jeffrey
Karajannis, Matthias
NEURO-ONCOLOGY, 2012, 14 : 19 - 19
[9] Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma
Plotkin, Scott R.
Allen, Jeffrey
Dhall, Girish
Campian, Jian L.
Clapp, D. Wade
Fisher, Michael J.
Jain, Rakesh K.
Tonsgard, James
Ullrich, Nicole J.
Thomas, Coretta
Edwards, Lloyd J.
Korf, Bruce
Packer, Roger
Karajannis, Matthias A.
Blakeley, Jaishri O.
NEURO-ONCOLOGY, 2023, 25 (08) : 1498 - 1506
[10] A clinical study of vestibular schwannomas in type 2 neurofibromatosis
Kishore, A
O'Reilly, BF
CLINICAL OTOLARYNGOLOGY, 2000, 25 (06) : 561 - 565

← 1 2 3 4 5 →